Company | Market Capitalization | Latest Funding Round | Key Innovations | Regulatory Approvals | Partnerships and Collaborations | Employee Count | Revenue Growth Rate | Awards and Recognitions | Market Focus Areas |
|---|---|---|---|---|---|---|---|---|---|
Elicio Therapeutics https://elicio.com | 89.02M | Elicio Therapeutics recently secured $10 million in a registered direct offering. This funding round | Elicio Therapeutics has developed several key innovations in the biotech sector, particularly in can | Elicio Therapeutics has reached alignment with the FDA regarding its ELI-002 product, indicating tha | Elicio Therapeutics has established several significant partnerships and collaborations in the biote | 32 | Not found | Not found | Elicio Therapeutics primarily focuses on developing cancer immunotherapies aimed at solid tumors, wi |
Candel Therapeutics https://candeltx.com | 263.10M | Candel Therapeutics recently announced a public offering to raise $80 million. This funding round wa | Candel Therapeutics has developed several key innovations and products in the biotech sector, primar | Candel Therapeutics has received several regulatory designations for its products, including Orphan | Candel Therapeutics has established several significant partnerships in the biotech industry, includ | 42 | Not found | Candel Therapeutics has received several awards and recognitions in the biotech field, including the | Candel Therapeutics primarily focuses on developing viral immunotherapies targeting various types of |
Gilead Sciences https://www.gilead.com | $139.34 billion | Gilead Sciences recently announced a funding initiative that includes a total of $12.6 million in gr | Gilead Sciences has developed several key innovations and products in the biotech sector, particular | Gilead Sciences has received several regulatory approvals for its products and technologies, includi | Gilead Sciences has established several significant partnerships and collaborations in the biotech i | 18,000 | -1% | Gilead Sciences has received several awards and recognitions in the biotech field, including: 1. 202 | Gilead Sciences primarily focuses on the following therapeutic areas: virology, oncology, and inflam |
BioNTech https://www.biontech.com/de/de/home.html | 21.85B | BioNTech has secured up to $145 million in funding from a global coalition against infectious diseas | BioNTech has developed several key innovations and products in the biotech sector, particularly in i | BioNTech has received several regulatory approvals for its products and technologies, primarily rela | BioNTech has established several significant partnerships and collaborations in the biotech industry | 6300 | -78% | BioNTech has received several awards and recognitions in the biotech field, including:
The German Su | BioNTech is primarily focused on the following therapeutic areas: 1. Oncology - Developing innovativ |
BioMarin Pharmaceutical https://www.biomarin.com | $13.03 billion | Not found | BioMarin Pharmaceutical has developed several key innovations and products in the biotech sector, pa | BioMarin Pharmaceutical has received several regulatory approvals for its products, including:
BRIN | BioMarin Pharmaceutical has established several significant partnerships and collaborations in the b | 3,401 | 15.42% | BioMarin Pharmaceutical has received several awards and recognitions in the biotech field, including | BioMarin Pharmaceutical primarily focuses on developing treatments for serious diseases and medical |
Ultragenyx Pharmaceuticals https://www.ultragenyx.com | $3.32 billion | Ultragenyx Pharmaceuticals is looking to raise approximately $350 million in a public stock offering | Ultragenyx Pharmaceuticals has developed several key innovations and products in the biotech sector, | Ultragenyx Pharmaceuticals has received several regulatory approvals for its products, including:
Bu | Ultragenyx Pharmaceuticals has established several significant partnerships and collaborations in th | 1276 | 19% | Ultragenyx Pharmaceuticals has received several awards and recognitions in the biotech field, includ | Ultragenyx Pharmaceuticals primarily focuses on developing therapies for rare and ultrarare genetic |
BeiGene https://beigene.com | 31.17B | Not found | BeiGene has developed several key innovations and products in the biotech sector, particularly in ca | BeiGene has received several regulatory approvals for its products, including:
TEVIMBRA (tislelizuma | BeiGene has established several significant partnerships and collaborations in the biotech industry, | 10,600 | 74% | BeiGene has received several awards and recognitions in the biotech field, including: 1. Manufacture | BeiGene primarily focuses on two therapeutic areas: Hematology and Solid Tumors. They are committed |
AstraZeneca https://www.astrazeneca.com | $224.51 billion | AstraZeneca recently announced a funding round involving a C$820 million (approximately US$570 milli | AstraZeneca has developed several key innovations and products in the biotech sector, including:
Bi | AstraZeneca has received several regulatory approvals for its products and technologies, including:
| AstraZeneca has established several significant partnerships and collaborations in the biotech indus | 89,900 | 3% | AstraZeneca has received several awards and recognitions in the biotech field, including:
The AstraZ | AstraZeneca primarily focuses on the following therapeutic areas: oncology, cardiovascular, renal, m |
UroGen Pharma https://www.urogen.com | 496.90M | UroGen Pharma announced a funding round on July 27, 2023, in which they raised approximately $120 mi | UroGen Pharma has developed several key innovations and products in the biotech sector, particularly | UroGen Pharma has received regulatory approvals for several products and technologies, including: 1. | UroGen Pharma has established several significant partnerships and collaborations in the biotech ind | 201 | Not found | Not found | UroGen Pharma primarily focuses on uro-oncology, specifically targeting treatments for urological ca |
Amgen https://www.amgen.com | $164.25 billion | Amgen borrowed $4 billion under a Term Loan Credit Agreement on October 6, 2023. This funding is par | Amgen has developed several key innovations and products in the biotech sector, including:
Enbrel ( | Amgen has received several regulatory approvals for its products and technologies, including: 1. LUM | Amgen has established several significant partnerships and collaborations in the biotech industry, i | 26,700 | 7% | Amgen has received several awards and recognitions in the biotech field, including:
Ranked #6 on For | Amgen primarily focuses on four therapeutic areas: general medicine, rare disease, inflammation, and |
AbbVie https://www.abbvie.com | $362.98 billion | AbbVie recently engaged in a funding round related to a partnership with EvolveImmune, which started | AbbVie has developed several key innovations and products in the biotech sector, including:
Humira | AbbVie has received several regulatory approvals for its products and technologies, including:
VYAL | AbbVie has established several significant partnerships and collaborations in the biotech industry, | 50,000 | -6.44% | AbbVie has received several awards and recognitions in the biotech field, including being named "Bio | AbbVie primarily focuses on several therapeutic areas, including Immunology, Oncology, Neuroscience, |
Pivot Bio https://www.pivotbio.com | $2 billion | Pivot Bio recently closed a $430 million Series D funding round on August 29, 2023. The funding was | Pivot Bio has developed several key innovations and products in the biotech sector, primarily focuse | Pivot Bio's products have received regulatory approvals from the USDA, FDA, and EPA in the United St | Pivot Bio has established several significant partnerships in the biotech industry, including:
A dis | 371-550 | 60% | Pivot Bio has received several awards and recognitions in the biotech field, including:
Recognition | Pivot Bio primarily focuses on the agricultural market, specifically targeting crop production throu |
Vertex Pharmaceuticals https://www.vrtx.com | $124.90 billion | Vertex Pharmaceuticals completed a Post-IPO Secondary funding round on July 10, 2024, raising approx | Vertex Pharmaceuticals has developed several key innovations and products in the biotech sector, par | Vertex Pharmaceuticals has received several regulatory approvals for its products and technologies, | Vertex Pharmaceuticals has established several significant partnerships and collaborations in the bi | 5400 | 10.51% | Vertex Pharmaceuticals has received several notable awards and recognitions in the biotech field, in | Vertex Pharmaceuticals primarily focuses on therapeutic areas including cystic fibrosis, sickle cell |
Arrowhead Pharmaceuticals https://arrowheadpharma.com | $1.74 billion | Arrowhead Pharmaceuticals announced a $500 million strategic senior secured credit facility on Augus | Arrowhead Pharmaceuticals has developed several key innovations and products in the biotech sector, | Arrowhead Pharmaceuticals has received several regulatory approvals and designations for its product | Arrowhead Pharmaceuticals has established significant partnerships in the biotech industry, notably | 525 | -1.03% | Not found | Arrowhead Pharmaceuticals is primarily focused on several therapeutic areas, including cardiometabol |
REGENXBIO https://www.regenxbio.com | 358.37M | REGENXBIO recently secured a strategic partnership with Nippon Shinyaku, which was announced in Marc | REGENXBIO has developed several key innovations and products in the biotech sector, particularly in | REGENXBIO has received several regulatory approvals and designations for its products and technologi | REGENXBIO has established several significant partnerships in the biotech industry, including:
Nipp | 353 | 45.3% | REGENXBIO has received several recognitions in the biotech field, including being awarded the Washin | REGENXBIO is primarily focused on developing gene therapy product candidates in the following therap |
SpringWorks Therapeutics https://www.springworkstx.com | 3.49B | The latest funding round for SpringWorks Therapeutics was a post-IPO round that took place on Septem | SpringWorks Therapeutics has developed key innovations in the biotech sector, particularly in oncolo | SpringWorks Therapeutics has received regulatory approvals for the following products:
GOMEKLI™ (mi | SpringWorks Therapeutics has established several significant partnerships and collaborations in the | 305 | 23% | SpringWorks Therapeutics received the 2021 Innovation in Medicine Award at the Children's Tumor Foun | SpringWorks Therapeutics primarily focuses on developing innovative medicines for rare tumors, hemat |
Invaio https://www.invaio.com | Not found | Not found | Invaio Sciences has developed several key innovations and products in the biotech sector focused on | Invaio Sciences has received regulatory approval from the Florida Department of Agriculture and Cons | Invaio Sciences has established several significant partnerships and collaborations in the biotech i | 90 | Not found | Invaio Sciences has been recognized as one of "America's Top GreenTech Companies 2024." However, the | Invaio Sciences primarily focuses on crop health solutions, specifically targeting areas such as tre |
Sanofi https://www.sanofi.com/en | $132.66 billion | Sanofi's latest funding round was for Agomab Therapeutics, which secured $89 million in Series D fun | Sanofi has developed several key innovations and products in the biotech sector, particularly focusi | Sanofi has received several regulatory approvals for its products and technologies, including:
Sarc | Sanofi has established several significant partnerships and collaborations in the biotech industry, | 86,088 | 5.11% | Sanofi has received several awards and recognitions in the biotech field, including:
Sanofi iDEA-TEC | Sanofi is primarily focused on several therapeutic areas, including immunology, neurology, oncology, |
Locus AG https://locusag.com | Not found | Not found | Locus AG has developed several key innovations and products in the biotech sector, particularly focu | Locus AG has received several regulatory approvals for its products, including the following notable | Locus AG has established several significant partnerships in the biotech industry, including:
A pa | 100+ | Not found | Locus AG has received several awards and recognitions in the biotech field, including:
NREL's Indust | Locus AG primarily focuses on biological solutions for various agricultural sectors, including row c |
Ionis Pharmaceuticals https://ionis.com | 4.52B | Ionis Pharmaceuticals recently completed a public offering, pricing 11,500,000 shares of its common | Ionis Pharmaceuticals has developed several key innovations and products in the biotech sector, part | Ionis Pharmaceuticals has received several regulatory approvals for its products, including:
TRYNGOL | Ionis Pharmaceuticals has established several significant partnerships and collaborations in the bio | 927 | 34% | Ionis Pharmaceuticals has received several awards and recognitions in the biotech field, including:
| Ionis Pharmaceuticals is primarily focused on therapeutic areas including neurology, cardiology, and |
Benson Hill https://bensonhill.com | $1.52M | Benson Hill recently filed for Chapter 11 bankruptcy protection and is seeking $11 million in financ | Benson Hill has developed several key innovations and products in the biotech sector, particularly f | Not found | Benson Hill has established several significant partnerships and collaborations in the biotech indus | 270 | 24% | Benson Hill has received several awards and recognitions in the biotech field, including:
Overall Fo | Benson Hill primarily focuses on three market areas: better feed, better food, and better fuel. Thes |
Corteva Agriscience https://www.corteva.com | $33.77B | Corteva Agriscience's latest funding round was a grant round that took place on May 11, 2023, in whi | Corteva Agriscience has developed several key innovations and products in the biotech sector, partic | Corteva Agriscience has received various regulatory approvals for its crop protection products, whic | Corteva Agriscience has established several significant partnerships and collaborations in the biote | 22,500 | -1% | Corteva Agriscience has received several awards and recognitions in the biotech field, including:
Th | Corteva Agriscience primarily focuses on three core market areas: Seeds, Crop Protection, and Digita |
Albatroz Therapeutics https://www.albatroztherapeutics.com | Not found | Albatroz Therapeutics recently secured $3 million in funding to develop therapies targeting tissue r | Albatroz Therapeutics is focused on developing first-in-class antibody therapeutics targeting a nove | Not found | Albatroz Therapeutics has established significant partnerships in the biotech industry, including: 1 | 10-25 | Not found | Albatroz Therapeutics received the first Golden Ticket prize from Amgen in Singapore, which recogniz | Albatroz Therapeutics is primarily focused on developing first-in-class antibodies targeting a novel |
Allozymes https://www.allozymes.com | Not found | Allozymes, a Singapore-based biotechnology company, raised $15 million in a Series A funding round. | Allozymes has developed several key innovations and products in the biotech sector, including:
A pro | Not found | Allozymes has established several significant partnerships in the biotech industry, including:
Coll | 35 | Not found | Allozymes has received several awards and recognitions in the biotech field, including:
The Future F | Allozymes is targeting several primary market focus areas, including:
Pharmaceuticals: Developing |
Hummingbird Bioscience https://hummingbirdbioscience.com | Not found | Hummingbird Bioscience was involved in a recent funding round through its licensing of technology to | Hummingbird Bioscience has developed several key innovations and products in the biotech sector, par | Hummingbird Bioscience has received regulatory approval from the UK Medicines and Healthcare product | Hummingbird Bioscience has established several significant partnerships and collaborations in the bi | 86 | Not found | Hummingbird Bioscience has received several awards and recognitions in the biotech field, including: | Hummingbird Bioscience primarily focuses on engineering biotherapeutics, particularly antibody-based |
Explore this dataset in full detail with Extruct AI. Our platform makes it easy to analyze, filter, and export the data for your specific research needs.
